Ligand validation:5UEG

86P: [[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl] hydrogen phosphate

86P is a Ligand Of Interest in 5UEG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5UEG_86P_C_101	83%	18%	0.096	0.955	1.96	1.61	6	11	0	0	100%	0.5
5UEG_86P_B_101	80%	17%	0.096	0.944	1.87	1.78	6	11	0	0	100%	0.5
5UEG_86P_A_101	80%	18%	0.102	0.95	1.99	1.57	7	11	0	0	100%	0.5
5UEG_86P_D_101	76%	14%	0.106	0.942	1.88	2.01	7	14	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.